Article info

PDF
Use of Ruthenium-106 Brachytherapy for Iris Melanoma: The Scottish Experience

Authors

  1. Correspondence to Dr Umiya Agraval, Tennent Institute of Ophthalmology, Gartnavel General Hospital, 1053 Great Western Road, Glasgow G12 0YN, UK; umiya.agraval{at}nhs.net
View Full Text

Citation

Agraval U, Sobti M, Russell HC, et al
Use of Ruthenium-106 Brachytherapy for Iris Melanoma: The Scottish Experience

Publication history

  • Received February 1, 2017
  • Revised April 24, 2017
  • Accepted April 29, 2017
  • First published June 9, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.